The type I interferon system in the etiopathogenesis of autoimmune diseases
Open Access
- 9 November 2011
- journal article
- review article
- Published by Uppsala Medical Society in Upsala Journal of Medical Sciences
- Vol. 116 (4), 227-237
- https://doi.org/10.3109/03009734.2011.624649
Abstract
Many patients with systemic autoimmune diseases have signs of a continuous production of type I interferon (IFN) and display an increased expression of IFN-alpha-regulated genes. The reason for the on-going IFN-alpha synthesis in these patients seems to be an activation of plasmacytoid dendritic cells (pDCs) by immune complexes (ICs), consisting of autoantibodies in combination with DNA or RNA-containing autoantigens. Such interferogenic ICs are internalized via the Fc gamma RIIa expressed on pDCs, reach the endosome, and stimulate Toll-like receptor (TLR)-7 or -9, which subsequently leads to IFN-alpha gene transcription. Variants of genes involved in both the IFN-alpha synthesis and response have been linked to an increased risk to develop systemic lupus erythematosus (SLE) and other autoimmune diseases. Among these autoimmunity risk genes are IFN regulatory factor 5 (IRF5), which is involved in TLR signaling, and the signal transducer and activator of transcription 4 (STAT4) that interacts with the type I IFN receptor. Several other gene variants in the IFN signaling pathway also confer an increased risk to develop an autoimmune disease. The observations that IFN-alpha therapy can induce autoimmunity and that many autoimmune conditions have an on-going type I IFN production suggest that the type I IFN system has a pivotal role in the etiopathogenesis of these diseases. Possible mechanisms behind the dysregulated type IFNsystem in autoimmune diseases and how the IFN-alpha produced can contribute to the development of an autoimmune process will be reviewed.Keywords
This publication has 101 references indexed in Scilit:
- A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLEEuropean Journal of Human Genetics, 2010
- How does interferon-α insult the vasculature? Let me count the waysArthritis & Rheumatism, 2010
- Genetic variants and disease‐associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosusArthritis & Rheumatism, 2010
- A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosusNature Genetics, 2009
- Recent insights into the genetic basis of systemic lupus erythematosusGenes & Immunity, 2009
- Association of the IRF5 risk haplotype with high serum interferon‐α activity in systemic lupus erythematosus patientsArthritis & Rheumatism, 2008
- Systemic IFN‐α drives kidney nephritis in B6.Sle123 miceEuropean Journal of Immunology, 2008
- A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5Human Molecular Genetics, 2008
- STAT4and the Risk of Rheumatoid Arthritis and Systemic Lupus ErythematosusNew England Journal of Medicine, 2007
- Pre-assembly of STAT4 with the human IFN-α/β receptor-2 subunit is mediated by the STAT4 N-domainMolecular Immunology, 2007